
Miraculins Files with Health Canada for PreVu Medical Device License
A class II medical device license application was filed for the Non-Invasive Skin Cholesterol Point of Care test
A class II medical device license application was filed for the Non-Invasive Skin Cholesterol Point of Care test
$400,000 in grants provide financial incentive to use biomass.
Thanks to combined investments of $1.2 million from the Governments of Canada and of Manitoba business leaders from around the world will have an opportunity to participate in Centralia 2012.
Congratulations to Conviron for winning Manitoba's Exporter of the Year and Intelligent Hospital Systems for winning the CME's Emerging award.
Centrallia 2012 is what we're calling speed-dating for business. We want to hook you up and help you build new relationships, so your business prospers.
DiaMedica announced the successful humanization of its monoclonal antibody DM-204 for Type 2 diabetes and diabetic related complications of hypertension and cholesterol.
Intelligent Hospital Systems is building its order book for its million-dollar robotic pharmaceutical dispensers
Intelligent Hospital Systems has announced the release of a new enhanced version of Robotic Intravenous Automation.
DiaMedica reported that chronic administration of DM-199 significantly delayed the autoimmune attack, preserved beta cell mass and demonstrated a 12-fold increase in circulating C-peptide levels in an in vivo study.
Medicure reported a first-quarter profit of $23.5 million, reversing a year-ago net loss of $1.6 million as it booked a $23.9-million non-cash gain on a debt settlement.
DiaMedica presented new compelling Type 2 diabetes data from studies of DM-204 at the Windhover Therapeutic Area Partnership Conference in Boston, MA, USA.
The $50 million Agricultural Innovation Program, which will boost the development and commercialization of innovative new products, technologies and processes in the agricultural sector was announced by Agriculture Minister Gerry Ritz.
GSK announced the launch of a new national fund that will significantly advance the commercialization of scientific innovation in Canada by investing in early stage breakthrough research.
Wendy Smith, a local prosthetist whose quest to build a better breast for women who have undergone a full or partial mastectomy just got a $97,000 financial boost from the federal government.
Business incubators are designed to help technology companies grow in all sorts of ways.
Last week, Burt Rutan, named Entrepreneur of the Year by Inc. magazine and one of "the world's 100 most influential people" by Time magazine, imparted some innovation tips to a Winnipeg audience with a vested interest in triggering more innovation-based e
Medicure Inc. is pleased to announce that the TSX Venture Exchange has granted approval for Medicure to graduate from the NEX, to the TSX Venture Exchange as a Tier 2 issuer.
Serious players in the biomaterials and bioenergy fields from around the world have converged on Winnipeg for the three-day BIOFIBE2011 Conference.
Ottawa needs to overhaul its flagship R & D program because it spends too much money and fails to show any increase in innovation among Canadian companies, says a federally appointed panel of experts.
As part of Small Business Week, the province is unveiling two new programs, AccessManitoba and Business Programs and Services (BizPaS) to help support small businesses and entrepreneurs set up shop, access services and provide better customer service, Ent
The Emerging Life Science Company of the Year award celebrates a company based in Manitoba that is recognized for their growth potential.
Newly launched MY Sleep Scoring API provides free access to leading sleep analysis metric, accelerating research into the clinical management of disrupted sleep.
Provinces and territories will have access to updated COVID-19 vaccines for their respective fall vaccination campaigns
Canadian health officials on Tuesday authorized Moderna's (MRNA.O) COVID-19 vaccine targeting the Omicron subvariant, urging all Canadians over the age of six months to get fresh inoculations as the nation sees an uptick in infections.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.